Dr. Dmitriy Nevelev, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 2,724
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
NY license 314481 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Hospital New York, NY
- Staten Island University Hospital Staten Island, NY
- Richmond University Medical Center Staten Island, NY
Medical groups
- North Shore-Lij Medical PC (6,440 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,724
- Services billed
- 6,023
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,320 | 1,640 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 718 | 392 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 675 | 648 |
| Established patient office or other outpatient visit, 30-39 minutes | 618 | 326 |
| New patient office or other outpatient visit, 45-59 minutes | 85 | 85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 76 | 76 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | 68 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 64 | 38 |
| Established patient office or other outpatient visit, 20-29 minutes | 55 | 51 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 54 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in Bronx, NY | 563 |
| Metoprolol Succinate Other prescribers in Bronx, NY | 448 |
| Atorvastatin Calcium Other prescribers in Bronx, NY | 425 |
| Amlodipine Besylate Other prescribers in Bronx, NY | 280 |
| Eliquis (apixaban) Other prescribers in Bronx, NY | 190 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Bronx, NY | 161 |
| Losartan Potassium Other prescribers in Bronx, NY | 154 |
| Furosemide Other prescribers in Bronx, NY | 135 |
| Ezetimibe Other prescribers in Bronx, NY | 132 |
| Metoprolol Tartrate Other prescribers in Bronx, NY | 129 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 7 payments worth $525 in total to this clinician.
| Amgen Inc. | $289 |
|---|---|
| Edwards Lifesciences Corporation | $108 |
| Medtronic, Inc. | $95.85 |
| Novo Nordisk Inc | $16.16 |
| Novartis Pharmaceuticals Corporation | $15.89 |
| Food and Beverage | $525 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,310 in research payments for these studies, mostly to the institutions running them.
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.